Exploration of a Model for Elimination of Hepatitis C in Women of Childbearing Age in Primary Hospitals in Southern China
Journal of Viral Hepatitis · 2026-04 · 33 (4)
DOI: 10.1111/jvh.70153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Viral Hepatitis, online erschienen am 19.03.2026. Verfasst von Li Guo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Beihai People's Hospital, Beihai, China. Hauptthemen laut MEDLINE: Hepatitis C, Disease Eradication. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Analysis of risk factors for the progression of chronic hepatitis B to liver cirrhosis and construction of clinical prediction models, Study on the Expression Levels of cytokines such as IL-2 and IFN-γ in the peripheral blood of HIV/AIDS Patients and their clinical significance.
Abstract (Originalsprache)
Hepatitis C virus (HCV) can be transmitted from mother to child, although data on HCV elimination in women of childbearing age remain limited. This study aimed to evaluate an intervention model aligning with the ‘treatment as prevention’ strategy. The ‘Hepatitis C Prevention and Treatment Project for Women of Childbearing Age (15–49 years)’, launched in October 2022, strengthened the use of HCV‐Ab screening, RNA testing, and treatment referral through multidisciplinary hospital collaborations. Key indicators (screening, RNA testing, and treatment rates) were compared between the pre‐intervention (October 2021–September 2022) and post‐intervention (October 2022–September 2023) periods. Additionally, a retrospective analysis of 503 HCV‐Ab‐positive women diagnosed between 2015 and 2024 was performed, together with a recall of the patients for RNA testing and treatment. The post‐intervention rates for screening rose from 41.5% to 66.2%, while those for RNA testing increased from 45.9% to 97.9%, and treatment from 52.6% to 97.3% (all p < 0.001). Among the 503 historical cases, 337 (67.0%) returned for follow‐up, with 92.5% completing RNA testing (312/337), 65.1% found to be RNA‐positive (203/312) and 91.3% began treatment (185/203). Of these, 98.9% (183/185) achieved SVR12 after direct‐acting antiviral therapy. Another 124 (24.7%) agreed to future testing. These findings demonstrated that targeted interventions significantly improve the rates of HCV diagnosis and treatment in women of childbearing age, enabling early detection and reducing the risk of transmission. This model offered a practical approach to eliminating HCV in this population, fulfilling the ‘treatment as prevention’ goal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Beihai People's Hospital, Beihai, China.
- Department of Preventive Medicine, Beihai People's Hospital, Beihai, China.
Förderung
- Analysis of risk factors for the progression of chronic hepatitis B to liver cirrhosis and construction of clinical prediction models
- Study on the Expression Levels of cytokines such as IL-2 and IFN-γ in the peripheral blood of HIV/AIDS Patients and their clinical significance
Zitieren
APA
Guo, L., Wu, W., Zhou, W., Liang, R., Lin, Y., Chen, Y., Wu, Y., Fei, J., Chen, Y., Ruan, L., Zeng, H., & Gao, B. (2026). Exploration of a Model for Elimination of Hepatitis C in Women of Childbearing Age in Primary Hospitals in Southern China. Journal of Viral Hepatitis, 33(4). https://doi.org/10.1111/jvh.70153
Vancouver
Guo L, Wu W, Zhou W, Liang R, Lin Y, Chen Y, et al. Exploration of a Model for Elimination of Hepatitis C in Women of Childbearing Age in Primary Hospitals in Southern China. Journal of Viral Hepatitis. 2026;33(4). doi:10.1111/jvh.70153
BibTeX
@article{Guo2026,
author = {Guo, Li and Wu, Wenbin and Zhou, Wen and Liang, Ruiting and Lin, Yan and Chen, Yuting and Wu, Yuping and Fei, Jing and Chen, YingPing and Ruan, Liyun and Zeng, Houyang and Gao, Bihua},
title = {Exploration of a Model for Elimination of Hepatitis C in Women of Childbearing Age in Primary Hospitals in Southern China},
journal = {Journal of Viral Hepatitis},
year = {2026},
volume = {33},
number = {4},
doi = {10.1111/jvh.70153}
}
EUVIMED